Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023- Japan

Publisher Name :
Date: 01-Nov-2016
No. of pages: 40
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Cervical Cancer- Market Insights, Epidemiology and Market Forecast-2023- Japan" Report provides marketed drugs information of Cervical Cancer. It includes historical and forecasted epidemiology and market size of the Cervical Cancer in Japan for 2013-2023. DelveInsight estimates that the therapeutic market size of Cervical Cancer in Japan will increase at a Compound Annual Growth Rate of 1.93% and reach up to USD 2.67 million by 2023. The global market size for prophylaxis treatment of Cervical Cancer is expected to grow at a CAGR of 0.71% and reach up to USD 2210.9 Million by 2023.

Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs, its patent and exclusivity details.

- The Report also covers the detailed global historical and forecasted epidemiological data for Japan from 2013-2023.

- It also provides Market size of Cervical Cancer for Japan from 2013 and forecasted Market size to 2023.

- The report will help in developing business strategies by understanding the trends shaping and driving the Japan market size of the Cervical Cancer

- Identifying patient populations in the Japan market of Cervical Cancer to improve product design, pricing, and launch plans.

- To understand the future market competition in Japan Cervical Cancer therapeutics market, as well as prophylaxis and Insightful review of the key market drivers and barriers.

Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023- Japan

Table of Contents

Report Introduction
Cervical Cancer Disease Overview
Types of Cervical Cancer
Staging of Cervical Cancer
Pathophysiology
Etiology
Risk Factors of Cervical Cancer
Diagnosisof Cervical Cancer
Epidemiology and Patient Population of Cervical Cancer
Japan
Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Japan (2016-2023)
Treatment Landscape
Treatment Algorithm
Treatment by Stages
Cervical Cancer Treatment Regimens
Current Unmet Needs
Cervical Cancer Emerging therapies Market Size
a) Bevacizumab (Avastin)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Avastin Historical Market Sales 2013-2015
Cost of therapy of Avastin
Cervical Cancer Prophylaxis Treatments
a) Cervarix (Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Cervarix Historical Market Sales 2012-2015
Cost of therapy of Cervarix
b) Gardasil/ Gardasil 9
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Gardasil Historical Market Sales 2012-2015
Cost of therapy of Gardasil
Pipeline Product (Phase III)
a) Z-100 (Ancer 20)
b) Axalimogene filolisbac or AXAL (ADXS11-001)
c) Gimeracil-Oteracil-Tegafur (S-1, TS-1)
Pipeline Product Analysis
Cervical Cancer Therapeutics Market in Japan
Historical market size of Japan (2013-2015)
Forecasted market size of Japan (2016-2023)
Cervical Cancer Prophylaxis Treatment Global
Historical Prophylaxis treatment market size (2013-2015)
Forecasted Prophylaxistreatment market size (2016-2023)
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Table 2: Forecasted Incident Cases of Cervical Cancer in Japan (2016-2023)
Table 3: Historical Cervical Cancer Therapeutics Market in Japan (2013-2015)
Table 4: Forecasted Cervical Cancer Therapeutics Market in Japan (2016-2023)
Table 5: Historical Cervical Cancer prophylaxis treatment global (2013-2015)
Table 6: Forecasted Cervical Cancer prophylaxis treatment global (2016-2023)

List of Figures

Figure 1: Pathophysiology ofCervical Cancer, 2016
Figure 2:Risk Factors ofCervical Cancer, 2016
Figure 3: Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Figure 4: Forecasted Incident Cases of Cervical Cancer in Japan (2016-2023)
Figure 5:Treatment Algorithm forCervical Cancer, 2016
Figure 6:Treatmentfor patients with Stage IA1 of Cervical Cancer, 2016
Figure 7:Treatmentfor patients with Stage IA2 of Cervical Cancer, 2016
Figure 8:Treatmentfor patients with Stage IB1 of Cervical Cancer, 2016
Figure 9:Treatmentfor patients with Stage IB2 to Stage IVAof Cervical Cancer, 2016
Figure 10:Treatmentfor patients with Stage IVB of Cervical Cancer, 2016
Figure11: Historical Cervical Cancer Therapeutics Market in Japan (2013-2015)
Figure12: Forecasted Cervical Cancer Therapeutics Market in Japan (2016-2023)
Figure13: Historical Cervical Cancer prophylaxis treatment global (2013-2015)
Figure14: Forecasted Cervical Cancer prophylaxis treatment global (2016-2023)
  • Global Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 01-Dec-2016        Price: US 3480 Onwards        Pages: 117
    Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it taxol.Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.Scope of the Report:This report ......
  • United States Malignant Melanoma Drug Market Report 2016
    Published: 29-Nov-2016        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Malignant Melanoma Drug Revenue, means the sales value of Malignant Melanoma Drug This report studies sales (consumption) of Malignant Melanoma Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - Enzon Pharmaceuticals - Exelixis - GlaxoSmithKline - Merck - Navidea Biopharmaceuticals......
  • Europe Lentinan Market Report 2016
    Published: 28-Nov-2016        Price: US 3900 Onwards        Pages: 124
    Notes: Sales, means the sales volume of Lentinan Revenue, means the sales value of Lentinan This report studies sales (consumption) of Lentinan in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Ajinomoto - Elicityl - Nammex - Panjin Gerun Biotech - Golden Horizon B......
  • Europe Doxorubicin Market Report 2016
    Published: 28-Nov-2016        Price: US 3900 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Doxorubicin Revenue, means the sales value of Doxorubicin This report studies sales (consumption) of Doxorubicin in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Johnson & Johnson - Sun Pharmaceutical Industries - Meiji Se......
  • United States Thyroid Cancer Drug Market Report 2016
    Published: 28-Nov-2016        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Thyroid Cancer Drug Revenue, means the sales value of Thyroid Cancer Drug This report studies sales (consumption) of Thyroid Cancer Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abott Laboratories - Genzyme - Eisai - Pfizer - Lannett - Mylan - Actavis - RLC Labs - Akrimax ......
  • United States Tamoxifen Market Report 2016
    Published: 25-Nov-2016        Price: US 3800 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Tamoxifen Revenue, means the sales value of Tamoxifen This report studies sales (consumption) of Tamoxifen in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Teva - Yangtze River Pharmaceutical Group - Chemische Fabrik Berg - PCAS - Suzhou Pharmaceutical Group - Forward Group - Shandong Health Pharmaceutica......
  • United States Letrozole Market Report 2016
    Published: 25-Nov-2016        Price: US 3800 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Letrozole Revenue, means the sales value of Letrozole This report studies sales (consumption) of Letrozole in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Teva - Actavis - Mylan - Fresenius Kabi - Endo - Apotex - Sun Pharma - Hengrui Split by product types, with sales, revenue, pric......
  • Global Triptorelin Acetate Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 21-Nov-2016        Price: US 3480 Onwards        Pages: 114
    Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appro......
  • Global Lentinan Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 10-Nov-2016        Price: US 3480 Onwards        Pages: 106
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiTechnologyake mushroom). Technology has been studied in Japan as a treatment for cancer. Scope of the Report: This report focuses on the Lentinan in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufac......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs